Another long-acting Methylphenidate (Metadate CD)
Methylphenidate is now available in a new extended-release formulation (Metadate CD - Celltech) for treatment of attention deficit/hyperactivity disorder (ADHD). The new product, which is a Schedule II controlled substance, is being advertised directly to consumers....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Another long-acting Methylphenidate (Metadate CD)
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1114
Article Code: 1114a
Date: October 1, 2001
Volume: 43
Pages: 83-84
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1114
Article Code: 1114a
Date: October 1, 2001
Volume: 43
Pages: 83-84
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)